Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
21.50
-0.61 (-2.76%)
Dec 5, 2025, 4:00 PM EST - Market closed
Tyra Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,148 | 731 | 596 | 318 | 572 | - | |
| Market Cap Growth | 40.29% | 22.61% | 87.61% | -44.42% | - | - | |
| Enterprise Value | 878 | 377 | 387 | 57 | 260 | - | |
| Last Close Price | 21.50 | 13.90 | 13.85 | 7.60 | 14.07 | - | |
| PB Ratio | 4.09 | 2.13 | 2.92 | 1.23 | 1.90 | - | |
| P/TBV Ratio | 4.09 | 2.13 | 2.92 | 1.23 | 1.90 | - | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.03 | 0.01 | 0.00 | 0.01 | |
| Quick Ratio | 17.45 | 23.53 | 13.32 | 44.07 | 83.57 | 8.19 | |
| Current Ratio | 17.71 | 23.81 | 13.81 | 45.13 | 84.09 | 8.22 | |
| Return on Equity (ROE) | -34.75% | -31.60% | -29.92% | -19.77% | -16.66% | -201.38% | |
| Return on Assets (ROA) | -23.08% | -22.09% | -20.31% | -12.86% | -10.18% | -70.27% | |
| Return on Capital (ROIC) | -24.04% | -23.25% | -21.21% | -13.08% | -10.36% | -120.22% | |
| Return on Capital Employed (ROCE) | -44.10% | -29.90% | -38.00% | -22.60% | -8.70% | -65.70% | |
| Earnings Yield | -9.73% | -11.83% | -11.59% | -17.41% | -4.60% | - | |
| FCF Yield | -7.95% | -9.63% | -8.54% | -16.00% | -4.27% | - | |
| Buyback Yield / Dilution | -11.70% | -33.98% | -1.96% | -203.94% | -793.58% | 41.81% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.